Follow the 쿼드메디슨 stock price and the full management transaction log of the company, a listed equity based in South Korea. Shares are listed on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 쿼드메디슨 has recorded 7 reports. Market capitalisation: €58.7bn. The latest transaction was reported on 31 August 2026 (Purchase). Among the most active insiders: 백승기. All data is accessible without an account.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Quad Medicine is a company operating in the healthcare and pharmaceutical sector, listed on the XKRX market. It focuses on developing innovative solutions to enhance healthcare.